For patients with polycystic kidney disease (PKD), a common genetic disorder that ravages the waste-removing organ with cysts, dialysis and transplantation are among the only treatments. More than 12.4 million people worldwide suffer from the dominant form of the condition. Now, geneticists have uncovered fresh details of how the disease progresses — findings that could open the door to new therapies.